Elkfork Partners’s CONMED CNMD Stock Holding History

Elkfork Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$425K	Hold	4,422	–	–	0.01%	625
2019 Q2	$378K	Hold	4,422	–	–	0.01%	666
2019 Q1	$368K	Hold	4,422	–	–	0.01%	647
2018 Q4	$284K	Hold	4,422	–	–	0.01%	684
2018 Q3	$350K	Buy	4,422 +1,078	+32%	+$83.4K	0.01%	704
2018 Q2	$245K	Hold	3,344	–	–	0.01%	732
2018 Q1	$212K	Hold	3,344	–	–	0.01%	767
2017 Q4	$170K	Buy	3,344 +594	+22%	+$30.9K	﹤0.01%	828
2017 Q3	$144K	Buy	2,750 +440	+19%	+$22.1K	﹤0.01%	814
2017 Q2	$118K	Buy	2,310 +1,144	+98%	+$56.6K	﹤0.01%	825
2017 Q1	$52K	Sell	1,166 -242	-17%	-$10.4K	﹤0.01%	888
2016 Q4	$62K	Buy	+1,408	New	+$59.8K	﹤0.01%	842

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Elkfork Partners's CNMD Position: Q3 2019 in Review

Elkfork Partners held its CONMED (CNMD) position steady in Q3 2019 at 4,422 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #625.

Elkfork Partners first reported a position in CNMD in Q4 2016 and has held it in 12 quarters since. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

Elkfork Partners held 4,422 shares of CONMED worth $425K as of Q3 2019.
Elkfork Partners left its CONMED share count unchanged in Q3 2019.
CONMED made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #625 holding.
Elkfork Partners first reported a position in CONMED in Q4 2016 and has held it in 12 quarters since.
234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.